Keywords: positive, ph, ii, data, 3m, aldara, pharmaceuticals
Positive Ph II data for 3M's Aldara
Article | 01 June 2001
3M Pharmaceuticals has reported results in the Journal of AmericanAcademy of Dermatology (May 2001) that demonstrated an almost 90% clearance of superficial ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
